COMPANY OVERVIEW

Leading the translation of RNA-modifying protein (RMP) biology into promising new therapies for cancer.

---

LOCATION

Lexington, MA, USA

---

THERAPEUTIC AREAS

Oncology

---

WEBSITE

https://www.accenttx.com

---

CAREER WEBSITE

https://www.accenttx.com/careers/

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Sep 21, 2023

Accent Therapeutics Bolsters Leadership Team with Key Executive Hires

Apr 16, 2023

Accent Therapeutics Presents Data Supporting DHX9 Inhibition as a Novel Therapeutic Modality at American Association for Cancer Research (AACR) Annual Meeting 2023

Apr 6, 2023

Accent Therapeutics to Present Data Supporting DHX9 Inhibition as a Novel Therapeutic Modality at American Association for Cancer Research (AACR) Annual Meeting 2023

Oct 18, 2021

Ipsen Adds Another Program Into Its Pre-Clinical RandD Oncology Pipeline Through an Exclusive Worldwide Collaboration With Accent Therapeutics, Targeting the RNA Modifying Protein, METTL3

Sep 28, 2020

Fierce Biotech Names Accent Therapeutics as One of Its “Fierce 15” Biotech Companies of 2020

For More Press Releases

---